Marshall Wace
ONSIW

Marshall Wace’s Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 ONSIW Stock Holding History

Marshall Wace’s Portfolio ONSIW Stock Details ONSIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-125,100
Closed -$24K – 916
2016
Q4 		$24K Hold
125,100
– – ﹤0.01% 948
2016
Q3 		$60K Hold
125,100
– – ﹤0.01% 915
2016
Q2 		$58K Buy
+125,100
New +$47.9K ﹤0.01% 962

Other funds holding ONSIW

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return

Marshall Wace's ONSIW Position: Q1 2017 in Review

Marshall Wace sold out of Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 (ONSIW) in Q1 2017, closing a stake of 125,100 shares — an estimated $24K sold.

Marshall Wace first reported a position in ONSIW in Q2 2016 and held it in 3 quarters. The position peaked at $60K in Q3 2016. 7 funds tracked by Wall St. Rank hold ONSIW as of Q1 2017.

  • Marshall Wace reported no remaining Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 position as of Q1 2017 after selling out during the quarter.
  • Marshall Wace sold 125,100 Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 shares in Q1 2017, an estimated $24K.
  • Marshall Wace first reported a position in Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 in Q2 2016 and held it in 3 quarters.
  • Marshall Wace's Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 position peaked at $60K in Q3 2016.
  • 7 funds tracked by Wall St. Rank held Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 as of Q1 2017.

Based on Marshall Wace's 13F filing for Q1 2017, filed 12 May 2017.